Key Takeaways DexCom received a warning letter from the Food and Drug Administration following inspections of two of its ...
Dexcom announced today that it received a warning letter from the FDA following inspections of two company facilities.
The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek ...
Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous ...
DexCom received a warning letter from the Food and Drug Administration following inspections of its San Diego and Mesa, Ariz.
Both warnings letters were issued after multiple inspections and following failures to respond to FDA 483a forms issued at ...
If drug tariffs don’t work, they could result in higher prices for American patients and increase drug shortages. Testing ...
Shortly after making an M&A play to break into the CDMO business, Granules’ manufacturing bona fides have come under fire in ...
USFDA issues warning letter for Granules India Gagillapur plant, new product approvals to take a hit
The USFDA issued a warning letter to Granules India Ltd's Gagillapur facility after an August 2024 inspection highlighted ...
DexCom DXCM-0.65%decrease; red down pointing triangle received a warning letter from the Food and Drug Administration following inspections of its San Diego and Mesa, Ariz. facilities and is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results